Detalles de la búsqueda
1.
Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate.
J Atten Disord
; 26(5): 696-705, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34085581
2.
Symptomatic and Functional Response and Remission From the Open-Label Treatment-Optimization Phase of a Study With DR/ER-MPH in Children With ADHD.
J Clin Psychiatry
; 82(4)2021 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34166587
3.
Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 31(3): 179-186, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33797983
4.
A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial.
Clin Ther
; 42(12): 2332-2340, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33168234
5.
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.
J Child Adolesc Psychopharmacol
; 30(1): 2-14, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464511
6.
Functional Impairment in Youth With ADHD: Normative Data and Norm-Referenced Cutoff Points for the Before School Functioning Questionnaire and the Parent Rating of Evening and Morning Behavior Scale, Revised.
J Clin Psychiatry
; 81(1)2019 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31846241
7.
Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults.
J Child Adolesc Psychopharmacol
; 29(3): 181-191, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30810347
8.
Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 28(1): 10-18, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29039979
9.
Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.
J Atten Disord
; 22(11): 1066-1073, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26700792
10.
Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 27(6): 474-482, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29172680
11.
Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior.
Psychopharmacology (Berl)
; 164(2): 193-9, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12404082
12.
Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
Brain Res
; 1001(1-2): 95-107, 2004 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-14972658
Resultados
1 -
12
de 12
1
Próxima >
>>